Corporation (NASDAQ: TECH), a global life sciences company valued at $11.45 billion, has announced the appointment of Dr. Amy E. Herr as an independent director on its Board of Directors. Dr. Herr ...

Shares of Bio-Techne Corp. TECH shed 2.04% to $72.05 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and ...

Taking a daily omega-3 supplement appears to slow down the rate of biological ageing by three months – and even more so if ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...

The stock's rise snapped a three-day losing streak.

Bio-Techne is expected to have witnessed the stabilization of large-pharma customers and an increase in biotech customers' ...

MINNEAPOLIS—Kim Kelderman, the Chief Executive Officer of Bio-Techne Corp (NASDAQ:TECH), recently executed a series of stock transactions involving the company's common stock. On January 27, Kelderman ...

The market seems to share this optimistic view, since Bio-Techne has a short interest of only 2.9% (this is the percentage of ...

Amid this shift, the providers and enablers of healthcare efficiency are well-positioned to reward investors. With an aging ...